Errors in data interpretation from genetic variation of human analytes

JCI Insight

Volumn 2, Issue 13, 2017, Pages

  Howie, Heather L ^a   Delaney, Meghan ^a,b   Wang, Xiaohong ^a   Er, Lay See ^a   Kapp, Linda ^a   Lebedev, Jenna N ^a   Zimring, James C ^a,b  

^a BloodWorks NW   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85042740369     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.94532     Document Type: Article

References (25)

1. Baker M. Reproducibility crisis: Blame it on the antibodies. Nature. 2015;521(7552):274–276.
2. Bradbury A, Plückthun A. Reproducibility: Standardize antibodies used in research. Nature. 2015;518(7537):27–29.
3. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520.
4. Cao RY, et al. Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection. PLoS One. 2013;8(5):e64024.
5. Cavacini LA, Kuhrt D, Duval M, Mayer K, Posner MR. Binding and neutralization activity of human IgG1 and IgG3 from serum of HIV-infected individuals. AIDS Res Hum Retroviruses. 2003;19(9):785–792.
6. Mathiesen T, Persson MA, Sundqvist VA, Wahren B. Neutralization capacity and antibody dependent cell-mediated cytotoxicity of separated IgG subclasses 1, 3 and 4 against herpes simplex virus. Clin Exp Immunol. 1988;72(2):211–215.
7. Scharf O, et al. Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J Virol. 2001;75(14):6558–6565.
8. Tay MZ, et al. Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses. PLoS Pathog. 2016;12(8):e1005817.
9. Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin. Clin Exp Immunol. 2005;139(3):542–550.
10. Huijbers MG, et al. The expanding field of IgG4-mediated neurological autoimmune disorders. Eur J Neurol. 2015;22(8):1151–1161.
11. Outschoorn IM, et al. Autoantibody heritability in thyroiditis: IgG subclass contributions. Autoimmunity. 2011;44(3):195–200.
12. Recke A, et al. Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation. J Autoimmun. 2010;34(4):435–444.
13. Michaelsen TE, Kornstad L. IgG subclass distribution of anti-Rh, anti-Kell and anti-Duffy antibodies measured by sensitive haemagglutination assays. Clin Exp Immunol. 1987;67(3):637–645.
14. Valenzuela NM, Hickey MJ, Reed EF. Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Front Immunol. 2016;7:433.
15. Beck LH. Lessons from a rare disease: IgG subclass and disease severity in alloimmune antenatal membranous nephropathy. Kidney Int. 2015;87(3):494–497.
16. Einarsdottir H, et al. H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn. Transfusion. 2014;54(3):665–671.
17. Einarsdottir HK, et al. On the perplexingly low rate of transport of IgG2 across the human placenta. PLoS ONE. 2014;9(9):e108319.
18. Stiehm RE. The four most common pediatric immunodeficiencies. Adv Exp Med Biol. 2007;601:15–26.
19. Zhao Y, Hammarstöm L. Selective IgG Subclass Deficiency. In: Lang F, ed. Encyclopedia of Molecular Mechanisms of Disease. Berlin: Springer Berlin Heidelberg; 2009:1913–1914.
20. Dugoujon JM, Hazout S, Loirat F, Mourrieras B, Crouau-Roy B, Sanchez-Mazas A. GM haplotype diversity of 82 populations over the world suggests a centrifugal model of human migrations. Am J Phys Anthropol. 2004;125(2):175–192.
21. Howie HL, et al. Serological blind spots for variants of human IgG3 and IgG4 by a commonly used anti-immunoglobulin reagent. Transfusion. 2016;56(12):2953–2962.
22. Bordeaux J, et al. Antibody validation. BioTechniques. 2010;48(3):197–209.
23. Gibb DR, et al. Type I interferon is necessary and sufficient for inflammation-induced RBC alloimmunization in mice. Journal of Immunology. In press.
24. Chu TH, Yazdanbakhsh K, Oyen R, Smart E, Reid ME. Production and characterization of anti-kell monoclonal antibodies using transfected cells as the immunogen. Br J Haematol. 1999;106(3):817–823.
25. Maecker HT, Frey T, Nomura LE, Trotter J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry A. 2004;62(2):169–173.